Code | 5960E | ||||||||||
MA number | 59/0084/24-S | ||||||||||
Product Form: | cps end 100x240 mg (fľ.HDPE) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 18.04.2024 |
Validity: | 18.04.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Dimethyl fumarate Teva Slovakia_04.2024.pdf |
SPC: | SPC_Dimethyl fumarate Teva Slovakia_04.2024.pdf |
Safety feature | Yes |
Data update: | 23.04.2024 |